Two novel nomograms predict 30-day mortality after off-pump coronary artery bypass grafting

Yangyan Wei1,2, Xincheng Gu2, Shengpeng Hu1

  • 1Department of Cardiac Surgery, Wuhan Asia General Hospital, Wuhan, 430022, China.

Heliyon
|July 2, 2024
PubMed

Insights

This study developed two nomograms to predict 30-day mortality after off-pump coronary artery bypass grafting (CABG). These tools offer accurate and convenient risk assessment for patients undergoing CABG surgery.

Area of Science:

  • Cardiovascular Surgery
  • Medical Informatics
  • Predictive Modeling

Background:

  • Off-pump coronary artery bypass grafting (CABG) mortality rates are declining.
  • There is a need for convenient and accurate predictive models for post-CABG mortality.
  • This study addresses the lack of reliable risk assessment tools for off-pump CABG.

Purpose of the Study:

  • To develop and validate two nomograms for predicting 30-day mortality after isolated off-pump CABG.
  • To identify key preoperative and intraoperative factors associated with mortality.
  • To provide clinicians with tools for earlier identification of high-risk patients.

Main Methods:

  • A cohort of 1840 patients undergoing isolated off-pump CABG was analyzed.
  • Lasso regression screened potential predictive factors, followed by multivariate logistic regression.
  • Two nomograms were constructed: one including preoperative and intraoperative variables, and another using only preoperative data.

Main Results:

  • The 30-day mortality rate was 3.97%.
  • Key predictors included age, low BMI, surgical time, creatinine, LVEF, stroke history, and intraoperative events.
  • Model 1 (preoperative & intraoperative) achieved an AUC of 0.836, significantly outperforming SinoScore.
  • Model 2 (preoperative only) had an AUC of 0.745.

Conclusions:

  • Two novel nomograms accurately predict 30-day mortality after isolated off-pump CABG.
  • These tools offer convenient risk assessment for clinical use.
  • The developed nomograms can aid in identifying high-risk patients for improved outcomes.
Abstract